← The Newsroom
Dr. Carpenter's Take · The Bone Health Brief

When Fractures Are on the Line, Anabolics Come Out on Top

In nearly 19,000 osteoporosis patients who had a shoulder replacement, those on anti-remodeling drugs before surgery had about a 1% higher risk of a broken bone around the implant within a year. Bone-building (anabolic) drugs were not tied to that risk. But this is a link, not a verdict on your treatment.

SC
Dr. Shannon CarpenterFounder & CEO · June 23, 2026

A new study in the Journal of Shoulder and Elbow Surgery looked at 18,922 osteoporosis patients who had a shoulder replacement for the first time. Here is the main finding. Patients taking anti-remodeling drugs before surgery (bisphosphonates, denosumab, raloxifene) had about a 1% higher risk of a periprosthetic humeral fracture within a year. That is a long phrase for a simple thing: a break in the bone around the implant. In this case, the upper arm bone (the humerus) where the new shoulder sits.

Here is the part that caught my eye. The anti-remodeling group carried that higher risk. But anabolic therapy, or bone-building therapy, was not tied to fracture at all. That fits a pattern I keep coming back to: the bone-building drugs often look good when we ask the hard questions. It is one more point in the anabolic-first conversation. It is not proof on its own.

Let me keep the numbers simple. In the full group, the difference works out to about 1% more fractures. In the reverse shoulder group, the link went away once the authors adjusted for other factors.

Now here is what I do not want you to hear. This is not a reason to stop your osteoporosis medication. This study looked back at insurance records, so it shows a link, not a cause. The authors also could not tell how bad each patient's osteoporosis was. And an untreated skeleton is the bigger danger by far.

What I take from this is watchfulness, not worry. If you are on a bisphosphonate and heading into a shoulder replacement, your surgeon may keep a closer eye on you afterward and take an X-ray sooner if pain hangs on. That is good care, not a red flag.

To me, the real lesson is timing. Get your bone health checked before you have a joint replacement, and a shoulder replacement especially. Know your numbers, and get treated for them, well before you are on the operating table. If you have a joint replacement coming up, bring your bones into that planning talk. Ask how your bone health fits the surgery plan, and ask whether your medication choice belongs in that talk too. That teamwork is exactly where prevention earns its keep.

And a word to my shoulder colleagues. Think about bone pre-optimization before you place a shoulder replacement. A periprosthetic fracture is a devastating complication, and the patient walking into your office for a shoulder is often the same patient whose bone health has never been looked at. If you have nowhere to send them, The Bone Health Clinic can help. Let us get those bones ready before the implant goes in.

Wondering about your own bone health?

Book a Consultation
The research behind this

In a retrospective study of 18,922 osteoporosis patients undergoing shoulder arthroplasty, preoperative anti-remodeling therapy was independently associated with increased odds of 1-year periprosthetic humeral fracture in the combined cohort (OR 1.25) and the anatomic cohort (OR 1.85), but not in the reverse cohort after adjustment; anabolic therapy showed no independent association, and there were no differences in acromial stress fracture or all-cause revision.

Eisenberg MT, Wang K, Lederman E, Amini MH, Krohn K, Patel M. Preoperative anti-remodeling osteoporotic therapy is associated with increased periprosthetic humeral fracture risk. J Shoulder Elbow Surg. 2026. doi:10.1016/j.jse.2026.04.065
Read the source study ↗